Synairgen plc (LON:SNG – Get Free Report)’s stock price shot up 15.6% during trading on Wednesday . The stock traded as high as GBX 4.44 ($0.06) and last traded at GBX 4.36 ($0.06). 101,284 shares changed hands during mid-day trading, a decline of 72% from the average session volume of 358,113 shares. The stock had previously closed at GBX 3.77 ($0.05).
Synairgen Stock Up 10.2 %
The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77. The stock has a market cap of £8.37 million, a price-to-earnings ratio of -94.25 and a beta of -2.23. The business’s 50 day moving average is GBX 4.15 and its 200 day moving average is GBX 5.26.
About Synairgen
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Read More
- Five stocks we like better than Synairgen
- Technology Stocks Explained: Here’s What to Know About Tech
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Financial Services Stocks Investing
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.
